Probing the specificity of aminoglycoside-ribosomal RNA interactions with designed synthetic analogs

Journal of the American Chemical Society

Volumn 120, Issue 9, 1998, Pages 1965-1978

  Alper, Phil B ^a   Hendrix, Martin ^a   Sears, Pamela ^a   Wong, Chi Huey ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; FRAMYCETIN; NEAMINE; PAROMOMYCIN; RIBOSOME RNA; RIBOSTAMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RNA BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0032507263     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja972599h     Document Type: Article

References (70)

1. (a) Tanaka, N. Mechanism of Action of Ammoglycoside Antibiotics. Handbook of Experimental Pharmacology; Springer-Verlag: New York, 1982; Vol. 62, p 221.
2. (b) Cundliffe, E. Recognition Sites for Antibiotics Within rRNA. In The Ribosome; Hill, W. E., et al. Eds.; American Society of Microbiology: Washington, DC, 1990; p 479.
3. (c) Noller, H. F. Annu. Rev. Biochem. 1991, 60, 191.
4. (a) Moazed, D.; Noller, H. F. Nature 1987, 327, 389.
5. (b) Puhroit, P.; Stern, S. Nature 1994, 370, 659.
6. (c) Recht, M. I.; Fourmy, D.; Blanchard, S. C.; Dahlquist, K. D.; Puglisi, J. D. J. Mol. Biol. 1996, 262, 421.
7. (d) Miyaguchi, H.; Narita, H.; Sakamoto, K.; Yokoyama, S. Nucleic Acids Res. 1996, 24, 3700.
8. Price, K. E.; Godfrey, J. C.; Kawaguchi, H. Adv. Appl. Microbiol. 1974, 18, 191.
9. (a) Zapp, M. L.; Stern, S.; Green, M. R. Cell 1993, 74, 969.
10. (b) Werstuck, G.; Zapp, M. L.; Green, M. R. Chem. Biol. 1996, 3, 129.
11. Mei, H.-Y.; Galan, A. A.; Halim, N. S.; Mack, D. P.; Moreland, D. W.; Sanders, K. B.; Truong, H. N.; Czarnik, A. W. Bioorg. Med. Chem. Lett. 1995, 5, 2755.
12. (a) von Ahsen, U.; Davies, J.; Schroeder, R. Nature 1991, 353, 368.
13. (b) von Ahsen, U.; Schroeder, R. Nucleic Acids Res. 1991, 19 (9), 2261.
14. (c) von Ahsen, U.; Davies, J.; Schroeder, R. J. Mol. Biol. 1992, 226 (4), 935.
15. (d) von Ahsen, U.; Noller, H. Science 1993, 260, 1500.
16. (a) Stage, T. K.; Hertel, K. J.; Uhlenbeck, O. C. RNA 1995, 1, 95.
17. (b) Clouet-d'Orval, B.; Stage, T. K.; Uhlenbeck, O. C. Biochemistry 1995, 34, 11186.
18. (a) Wang, Y.; Rando, R. R. Chem. Biol. 1995, 2, 281.
19. (b) Lato, S. M.; Boles, A. R.; Ellington, A. D. Chem. Biol. 1995, 2, 291.
20. (c) Wallis, M. G.; von Ahsen, U.; Schroeder, R.; Famulok, M. Chem. Biol. 1995, 2, 543.
21. (d) Famulok, M.; Huttenhofer, A. Biochemistry 1996, 35, 4265.
22. (e) Wang, Y.; Killian, J.; Hamasaki, K.; Rando, R. R. Biochemistry 1996, 35, 12338.
23. Hendrix, M.; Alper, P. B., Priestley, E. S.; Wong, C.-H. Angew. Chem., Int. Ed. Engl. 1997, 36, 95.
24. Park, W. K. C.; Auer, M.; Jaksche, H.; Wong, C.-H. J. Am. Chem. Soc. 1996, 118, 10150.
25. (a) Wang, H.; Tor, Y. Bioorg. Med. Chem. Lett. 1997, 7, 1951.
26. (b) Wang, H.; Tor, Y. J. Am. Chem. Soc. 1997, 119, 8734.
27. (a) Ratmeyer, L. S.; Vinayak, R.; Zon, G.; Wilson, W. D. J. Med. Chem. 1992, 35 (5), 966.
28. (b) Wilson, W. D.; Ratmeyer, L.; Zhao, M.; Strekowski, L.; Boykin, D. Biochemistry 1993, 32, 4098.
29. (c) Wilson, W. D.; Ratmeyer, L.; Cegla, M. T.; Spychala, J.; Boykin, D.; Demounynck, M.; Lhomme, J.; Krishnan, G. New J. Chem. 1994, 18, 419.
30. (d) McConnaughie, A. W.; Spychala, J.; Zhao, M.; Boykin, D.; Wilson, W. D. J. Med. Chem. 1994, 37, 1063.
31. (e) Zhao, M.; Ratmeyer, L.; Peloquin, R. G.; Yao, S.; Kumar, A.; Spychala, J.; Boykin, D. W.; Wilson, W. D. Bioorg. Med. Chem. 1995, 3 (6), 785.
32. (f) Fernandez-Saiz, M.; Schneider, H.-J.; Sartorius, J.; Wilson, W. D. J. Am. Chem. Soc. 1996, 175, 4739.
33. Fourmy, D.; Recht, M. I.; Blanchard, S. C.; Puglisi, J. D. Science 1996, 274, 1367.
34. Hendrix, M.; Priestley, E. S.; Joyce, G. F.; Wong, C.-H. J. Am. Chem. Soc. 1997, 119, 3641.
35. For antibiotic testing protocols, see: (a) Disk testing protocols: Phillips. I.; Williams, D. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978: pp 3-30. (b) MIC determination: Waterworth, P. M. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978; pp 31-40, Barry, A. L. The Antimicrobic Susceptibility Test: Principles and Practice; Lea and Febiger: Philadelphia, 1976. (c) Standards: Lorian, V. Antibiotics in Laboratory Medicine, 2nd ed.; Williams and Wilkins: Baltimore, 1986.
36. For antibiotic testing protocols, see: (a) Disk testing protocols: Phillips. I.; Williams, D. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978: pp 3-30. (b) MIC determination: Waterworth, P. M. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978; pp 31-40, Barry, A. L. The Antimicrobic Susceptibility Test: Principles and Practice; Lea and Febiger: Philadelphia, 1976. (c) Standards: Lorian, V. Antibiotics in Laboratory Medicine, 2nd ed.; Williams and Wilkins: Baltimore, 1986.
37. For antibiotic testing protocols, see: (a) Disk testing protocols: Phillips. I.; Williams, D. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978: pp 3-30. (b) MIC determination: Waterworth, P. M. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978; pp 31-40, Barry, A. L. The Antimicrobic Susceptibility Test: Principles and Practice; Lea and Febiger: Philadelphia, 1976. (c) Standards: Lorian, V. Antibiotics in Laboratory Medicine, 2nd ed.; Williams and Wilkins: Baltimore, 1986.
38. For antibiotic testing protocols, see: (a) Disk testing protocols: Phillips. I.; Williams, D. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978: pp 3-30. (b) MIC determination: Waterworth, P. M. In Laboratory Methods in Antimicrobial Chemotherapy; Garrod, L., Ed.; Churchill Livingstone Press: Edinburgh, 1978; pp 31-40, Barry, A. L. The Antimicrobic Susceptibility Test: Principles and Practice; Lea and Febiger: Philadelphia, 1976. (c) Standards: Lorian, V. Antibiotics in Laboratory Medicine, 2nd ed.; Williams and Wilkins: Baltimore, 1986.
39. For the total synthesis of neomycin B, see: (a) Usui, T.; Umezawa, S. J. Antibiot. 1987, 1464. (b) Usui, T.; Umezawa, S. Carbohydr. Res. 1987, 133.
40. For the total synthesis of neomycin B, see: (a) Usui, T.; Umezawa, S. J. Antibiot. 1987, 1464. (b) Usui, T.; Umezawa, S. Carbohydr. Res. 1987, 133.
41. Ford, J. H.; Bergy, M. E.; Brooks, A. A.; Garrett, E. R; Alberti, J.; Dryer, J. R.; Carter, H. E. J. Am. Chem. Soc. 1955, 77, 5311.
42. (a) Suami, T.; Nishiama, S.; Ihikawa, Y.; Katsura, S. Carbohydr. Res. 1976, 52, 187.
43. (b) Suami, T.; Nishiyama, S.; Ishikawa, Y.; Katsura, S. Carbohydr. Res. 1977, 53, 239.
44. (c) Suami, T.; Nishiyama, S.; Ishikawa, Y.; Katsura, S. Carbohydr. Res. 1977, 56, 415.
45. (d) Canas-Rodriguez, A.; Ruiz-Proveda, S. G. Carbohydr. Res. 1977, 58, 379.
46. (e) Suami; T.; Nishiyama, S; Ihikawa, Y.; Katsura, S. Carbohydr. Res. 1978, 65, 57.
47. (f) Pfeiffer; F. R.; Schmidt, S. J.; Kinzig; C. M.; Hoover, J. R. E.; Weisbach, J. A. Carbohydr. Res. 1979, 72, 119.
48. (a) Umezawa, S.; Koto, S.; Tatsuta, K.; Hineno, H.; Nishimura, Y.; Tsumura, T. Bull. Chem. Soc. Jpn. 1969, 42, 537.
49. (b) Umezawa, S.; Takagi, Y.; Tsuchia, T. Bull. Chem. Soc. Jpn. 1971, 44, 1411.
50. (d) Kumar, V.; Remers, W. A. J. Org. Chem. 1978, 43, 3327.
51. (d) Kumar, V.; Jones, G. S., Jr.; Blacksberg, I.; Remers, W. A.; Misiek, M.; Pursiano, T. A. J. Med. Chem. 1980, 23, 42.
52. (e) Sharma, M. N.; Kumar, V.; Remers, W. A. J. Antibiot. 1982, 35, 905.
53. (a) Grapsas, I.; Cho, Y. I.; Mobashery, S. J. Org. Chem. 1994, 59, 1918.
54. (b) Roestamadji, J.; Grapsas, I.; Mobashery, S. J. Am. Chem. Soc. 1995, 117, 80.
55. (a) Tsuchia, T.; Takagai, Y.; Umezawa, S. Tetrahedron Lett. 1979, 51, 4951.
56. (b) Reid, R. J.; Mizsak, S. A.; Reineke, L. M.; Zurenko, G. E.; Stern, K. F.; Magerlein, B. J. J. Med. Chem. 1981, 24, 1487.
57. Alper, P. B.; Hung, S.-C.; Wong, C.-H. Tetrahedron Lett. 1996, 37, 6029.
58. Vasella, A.; Witzig, C.; Chiara, J.-L.; Martin-Lomas, M. Helv. Chim. Acta 1991, 74, 2073.
59. (a) Yanagisawa, H.; Kinoshita, M.; Nadaka, S.; Umezawa, S. Bull. Chem. Soc. Jpn. 1970, 43, 246.
60. (b) Wanatabe, I.; Tsuchia, T.; Takase, T.; Umezawa, S.; Umezawa, H. Bull. Chem. Soc. Jpn. 1977, 50, 2369.
61. The desired β anomer featured no coupling to H2″ whereas the a anomer had a coupling constant of 4 Hz.
62. Lamberth, C.; Bednarski, M. D. Tetrahedron Lett. 1991, 32, 7369.
63. (a) Paulsen, H. Methods Cabohydr. Chem. 1972, 6, 142-148.
64. (b) Horton, D.; Tsai, J.-H. Methods Carbohydr. Chem. 1980, 8, 177.
65. (c) Andrews, G. C.; Crawford, T. C.; Bacon, B. E. J. Org. Chem. 1981, 46, 2976.
66. (d) Medakovic, D. Carbohydr. Res. 1994, 253, 299.
67. Semeria, D.; Philippe, M.; Delaumeny, J.-M.; Sepulchre, A.-M.; Gero, S. D. Synthesis 1983, 710.
68. 4 led to the decomposition of the azide prior to liberation of the anomeric center.
69. Use of benzyl bromide instead of allyl bromide as an electrophile led to decomposition under conditions necessary for reaction while Lewis acid promoted benzylation with benzyl 2,2,2-trichloroacetimidate led to reclosure to 28.
70. Laguzza, B.; Ganem, B. Tetrahedron Lett. 1981, 22, 1483.